BioVaria on 27/28 April 2026 in Munich will bring together Europe's leading technology transfer experts, innovators from academia and start-ups with investors and representatives of the global biotech and pharmaceutical industry.
Organized by Ascenion and other European technology transfer companies, BioVaria brings together potential licensees and investors from the biotechnology and pharmaceutical industries with scientists, founders and technology transfer experts from all over Europe.
On April 27 & 28, 2026, first-class research institutions, universities and university hospitals will present around 70 selected, licensable life science technologies. This year again, projects in early stages of development will also be presented, including projects from Ascenion's Life Science Digital Hub, which is funded by GO-Bio initial.
BioVaria Startup Pitch & Partner
The interactive BioVaria Startup Pitch & Partner Program offers spin-offs from all life-science areas (pharma, diagnostics, medtech and digital health)
- the possibility to present their technology and business concept
- direct exchange with potential VCs and investors during speed dating
- the opportunity to network with representatives of the industry and the life science scene
Applications are open to pre- and post-seed start-ups. Start-ups selected by an expert jury of investors will then compete live on the BioVaria stage for a "BioVaria Startup Award" worth up to 2,000 euros.
The application deadline for start-ups is February 15, 2026.
The application form can be found on BioVaria Startup Pitch & Partner Program